Objectives In this review paper, the pros and cons of the available pharmacological options
for the treatment of uterine fibroids are explored, including oral progestogens, levonorgestrel …

Uterine fibroids are the most common benign neoplasm of the female reproductive tract in
reproductive age women. Their prevalence is age dependent and can be detected in up to …

Introduction: The therapy of symptomatic uterine fibroids is based on surgery in the majority
of cases. Conservative medical treatment in cases of contraindication against operative …

Uterine fibroids (also known as leiomyomas or myomas) are the most common form of
benign uterine tumors. Current management strategies mainly involve surgical interventions …

Uterine fibroids (leiomyomas or myomas), benign monoclonal tumors, are the most common
benign tumors in women. Heavy or prolonged menstrual bleeding, abnormal uterine …

Uterine fibroids (also known as leiomyomas or myomas) are the most common form of
benign uterine tumors. Clinical presentations include abnormal bleeding, pelvic masses …

Introduction: Uterine fibroids (also known as leiomyomas or myomas) are the most common
form of benign uterine tumors. Current management strategies involve mainly surgical …

Uterine fibroids are the most common benign uterine tumours. Clinical symptoms include
abnormal bleeding, pelvic pressure, pelvic pain, infertility and obstetric complications …

Oral ulipristal acetate (Esmya®; Fibristal®), a synthetic selective progesterone receptor
modulator, is the first selective progesterone modulator to be approved for the treatment of …

Various treatment options have been proposed for the management of human symptomatic
uterine fibroids (or myomas). Despite this, the most popular one is surgery (myomectomy or …